Path- WBC Neoplasias Gomez Flashcards
proliferation centers
Small lymphocytic lymphoma
prolymphocyte
small lymphocytic lymphoma
smudge cells
chronic lymphocytic leukemia
peripheral T-cell lymphoma, unspecified
clinical features
mainly older adults; usually presents with lymphadenopathy; aggressive
T-cell neoplasm in children
anaplastic large-cell lymphoma
anaplastic large-cell lymphoma, genotype
ALK
anaplastic large-cell lymphoma, morphology finding
hallmark cells (horseshoe/kidney shaped)
ALK+ vs ALK-
ALK+ = can be treated, better prognosis. usually seen in children. ALK- = cannot be easily treated, worse prognosis, usually seen in older pt's
adult t-cell leukemia/lymphoma, genotype
HTLV-1
adult t-cell leukemia/lymphoma, cell marker
CD25, CD4
adult t-cell leukemia/lymphoma, clinical features
hypercalcemia cutaneous lesions marrow involvement pt's from Japan, West Africa, Caribbean aggressive
adult t-cell leukemia/lymphoma, morphology finding
cloverleaf nuclei
mycosis fungoides aka
Sézary syndrome
mycosis fungoides, clinical features
adults with cutaneous patches, plaques, nodules, or generalized erythema
indolent
Sezary syndrome
generalized exfoliative erythroderma
mycosis fungoides, morphologic finding
cerebriform nuclei
large granular lymphocytic leukemia, types
Cytotoxic T cell: indolent
NK cell: aggressive
large granular lymphocytic leukemia, associated syndrome
Felty syndrome
Felty syndrome
RA
splenomegaly
neutropenia
large granular lymphocytic leukemia, clinical features
adult pt with splenomegaly, neutropenia, anemia, sometimes accompanied by autoimmune disease
extranodal NK/T-cell lymphoma, genotype
EBV-associated
extranodal NK/T-cell lymphoma, cell marker
CD56
extranodal NK/T-cell lymphoma, clinical features
Adults with destructive extra nodal masses, most commonly sinonasal Aggressive. Midline lesions. Poor response to chemotherapy. Small vessel invasion.
MCC of acute leukemia associated with Down Syndrome
acute lymphoblastic leukemia
lymphoblastic neoplasms, special stains
PAS/Myeloperoxidase
B-cell acute lymphoblastic leukemia/lymphoma, genotype
chromosomal translocations (hyperdploidy)
t(12;21) involving RUNX1 and ETV6
t(9,22) BCR-ABL1
B-cell acute lymphoblastic leukemia/lymphoma, clinical features
predominantly children –> epistaxis and bleeding gums
sx relating to marrow replacement and pancytopenia
aggressive
B-cell acute lymphoblastic leukemia/lymphoma, cell markers
CD19, PAX5, sIg -, TdT +
B-cell acute lymphoblastic leukemia/lymphoma, prognosis
good for peds
bad for adults
T-cell acute lymphoblastic leukemia/lymphoma, genotype
chromosomal translocations
NOTCH1 in 70%
T-cell acute lymphoblastic leukemia/lymphoma, clinical features
predominantly adolescent males
thymic mass
variable bone marrow involvement
aggressive
T-cell acute lymphoblastic leukemia/lymphoma, cell markers
CD1, 2, 5, 7, TdT+
Hodgkin lymphoma, most common subtype
nodular sclerosis
nodular sclerosis, morphologic finding
lacunar cells
nodular sclerosis, genotype
EBV+
nodular sclerosis, cell markers
PAX5, CD15, CD30
nodular sclerosis, epidemiology
young patients, M=F
most common form of Hodgkin lymphoma in patients >50y/o
mixed cellularity
mixed cellularity Hodgkin lymphoma, cell markers
CD15, PAX5, CD30
mixed cellularity Hodgkin lymphoma, genotype
EBV+
nodular sclerosis, clinical features
usually stage I or II disease
frequent mediastinal involvement
young pt
mixed cellularity, clinical features
> 50% present as stage III or IV disease
M>F
Hodgkin Lymphomas, list subtypes
Classic
- Nodular sclerosis
- Mixed cellularity
- Lymphocyte rich
- Lymphocyte depletion
Lymphocyte predominance
lymphocyte predominance Hodgkin lymphoma, morphologic finding
L&H (popcorn cell)
lymphocyte predominance Hodgkin lymphoma, cell markers
CD20+ CD15- CD30- EBV- BCL6+
lymphocyte predominance Hodgkin lymphoma, clinical features
young males
cervical or axillary lymphadenopathy
mediastinal
Hodgkin lymphoma of developing countries and HIV-infected individuals
Lymphocyte depletion
Diagnostic morphologic finding of Hodgkin lymphomas
Reed sternburg cells
SLL/CLL genotype
Trisomy 13q = good prognosis
IGVH mutation = Zap70(-), CD38(-) = good prognosis
SLL/CLL clinical features
older pt
bone marrow, lymph node, spleen, and liver disease
indolent
follicular lymphoma, genotype
t(14;18) creating BCL2-IgH fusion gene
follicular lymphoma, cell of origin
centroblasts and centrocytes in the germinal center
follicular lymphoma, clinical features
older pt with generalized lymphadenopathy and marrow involvement
indolent (MCC indolent lymphoma)
low-grade splenic involvement
follicular lymphoma, cell markers
CD19, 20, 10, sIg, BCL6
diffuse large b-cell lymphoma, genotype
diverse chromosomal rearragements
BCL6
BCL2
c-MYC
diffuse large b-cell lymphoma, clinical features
all ages, but most common in adults often appears as a rapidly growing mass 30% extranodal aggressive high-grade splenic involvement
diffuse large b-cell lymphoma, types
- Mediastinal (young females, involving viscera and CNS)
- Immunodeficiency (HIV pt’s, etc)
- Body cavity/Primary effusion (KSHV/HHV8 pt’s with HIV)
Auer rods
acute myelogenous leukemia
acute promyelocytic leukemia, genotype
t(15;17)
Retinoic acid receptor α (RARA) gene on chromosome 17
PML gene on chromosome 15
PML/RARA fusion proteins block differentiation at promyelocyte
CD34 - marker for…
multipotent stem cells
CD64 - marker for…
mature myeloid cells
CD33 - marker for…
immature myeloid cells
CD15 - marker for…
more mature myeloid cells
bevacizumab’s antigen
VEGF
cetuximab’s antigen
EGFR
rituximab’s antigen
CD20
trastuzumab’s antigen
HER2/neu
t(15;17)
APL, PML-RARA fusion gene
inv(16)
AML M4
Myelocytic and monocytic differentiation; abnormal eosinophilic precursors in marrow with abnormal basophilic granules
APL treatment
all trans retinoic acid
Unique complication of APL
DIC
Most common myelocytic leukemia in Down Syndrome
acute megakaryoblastic leukemia
Pseudo-Pelger-Hüet cells
Myelodysplastic syndrome
Neutrophils with two nuclear lobes & abnormal granules
CML, most common translocation
BCR-ABL
Ringed sideroblasts
Myelodysplastic syndrome
polycythemia vera mutation
JAK2 V617F (in 95% of PV patients!)
treatment for CML
Imatinib
essential thrombocythemia mutation
JAK2
leukoerythroblastosis in blood smear is seen with…
primary myelofibrosis
primary myelofibrosis mutation
JAK2
dacryocytes
primary myelofibrosis
Langerhans cell Histiocytosis, morphologic finding
Birbeck granules
Langerhans cell histiocytosis AKA
eosinophilic granuloma
Hand-Schuller-Christian triad
calvarial bone defects
diabetes insipidus
exophthalmos